| 1 |
prostate-specific membrane antigen
(2737 times)
|
Nuclear Medicine
(756 times)
|
PCa (419 times)
PSA (361 times)
PET (351 times)
|
1995 Effect of exogenous testosterone replacement on prostate-specific antigen and prostate-specific membrane antigen levels in hypogonadal men.
|
| 2 |
poly(styrene-co-maleic anhydride)
(44 times)
|
Biotechnology
(10 times)
|
PEI (5 times)
NPs (4 times)
DA (3 times)
|
2004 Poly(L-lysine)-mediated immobilisation of oligonucleotides on carboxy-rich polymer surfaces.
|
| 3 |
propensity score-matched analysis
(20 times)
|
General Surgery
(8 times)
|
HR (4 times)
CI (3 times)
OS (3 times)
|
2016 Improved survival with combined modality therapy in the modern era for primary mediastinal B-cell lymphoma.
|
| 4 |
progressive spinal muscular atrophy
(7 times)
|
Neurology
(7 times)
|
ALS (4 times)
MND (3 times)
CIDP (2 times)
|
1983 Epidemiology of motor neuron disease in northern Sweden.
|
| 5 |
68Ga-PSMA-PET-CT
(3 times)
|
Urology
(2 times)
|
BF (1 time)
BMI (1 time)
BNI (1 time)
|
2016 [Uncommon manifestation of prostate cancer : Sister Mary Joseph's nodule].
|
| 6 |
poly(4-styrenesulfonic acid-co-maleic acid)
(3 times)
|
Environmental Health
(1 time)
|
CIP (1 time)
MNPs (1 time)
MSPE (1 time)
|
2012 In situ study of binding of copper by fulvic acid: comparison of differential absorbance data and model predictions.
|
| 7 |
polymerized small-molecule acceptor
(3 times)
|
Polymers
(1 time)
|
PCE (2 times)
all-PSC (1 time)
all-PSCs (1 time)
|
2022 Efficient All-Polymer Solar Cells with Sequentially Processed Active Layers.
|
| 8 |
primary sensorimotor area
(3 times)
|
Neurosciences
(1 time)
|
ALFFs (1 time)
ALS (1 time)
ALSFRS-R (1 time)
|
1980 Somatosensory evoked potentials: abnormalities with focal brain lesions remote from the primary sensorimotor area.
|
| 9 |
68Ga-PSMA-11
(2 times)
|
Neoplasms
(1 time)
|
PCa (2 times)
ADT (1 time)
bPFS (1 time)
|
2019 Randomized prospective phase III trial of 68Ga-PSMA-11 PET/CT molecular imaging for prostate cancer salvage radiotherapy planning [PSMA-SRT].
|
| 10 |
Ga-PSMA
(2 times)
|
Neoplasms
(1 time)
|
HR (2 times)
ADT (1 time)
ADT-FS (1 time)
|
2023 Prognostic factors of overall and prostate-specific antigen-progression-free survival in metastatic castration-resistant prostate cancer patients treated with 177 Lu-PSMA-617. A single-center prospective observational study.
|
| 11 |
paraspinous muscle area
(2 times)
|
General Surgery
(1 time)
|
PMA (2 times)
aSMA (1 time)
CT (1 time)
|
2017 Reduced paraspinous muscle area is associated with post-colectomy complications in children with ulcerative colitis.
|
| 12 |
poly(styrene-methyl methacrylate-acrylic acid)
(2 times)
|
Polymers
(1 time)
|
MO (1 time)
PANI (1 time)
St (1 time)
|
2011 Imitation of variable structural color in Paracheirodon innesi using colloidal crystal films.
|
| 13 |
PRO-SELF: Mouth Aware
(2 times)
|
Neoplasms
(2 times)
|
HNC (1 time)
RT (1 time)
|
1998 The PRO-SELF Mouth Aware program: an effective approach for reducing chemotherapy-induced mucositis.
|
| 14 |
prostate membrane-specific antigen
(2 times)
|
Radiotherapy
(1 time)
|
EGFR (1 time)
FR (1 time)
mpMRI (1 time)
|
2011 Retargeting vesicular stomatitis virus using measles virus envelope glycoproteins.
|
| 15 |
prostate surface membrane antigen
(2 times)
|
Biomedical Engineering
(1 time)
|
CTCs (1 time)
NOD/SCID (1 time)
PBMCs (1 time)
|
2016 An integrated microfluidic chip for immunomagnetic detection and isolation of rare prostate cancer cells from blood.
|
| 16 |
prostatic membrane antigen
(2 times)
|
Histology
(1 time)
|
PIN (1 time)
|
2004 Expression of prostate specific membrane antigen (PSMA) in prostatic adenocarcinoma and prostatic intraepithelial neoplasia.
|
| 17 |
anti-prostate membrane antigen
(1 time)
|
Biology
(1 time)
|
LNP (1 time)
LNPs (1 time)
|
2017 PET imaging of 64Cu-DOTA-scFv-anti-PSMA lipid nanoparticles (LNPs): Enhanced tumor targeting over anti-PSMA scFv or untargeted LNPs.
|
| 18 |
Ga-PSMA-HBNED-CC
(1 time)
|
Nuclear Medicine
(1 time)
|
eBCR (1 time)
RP (1 time)
|
2019 Impact of Ga-68-PSMA PET/CT on management in prostate cancer patients with very early biochemical recurrence after radical prostatectomy.
|
| 19 |
parental self-medication with antibiotics
(1 time)
|
Global Health
(1 time)
|
KAP (1 time)
|
2021 Understanding parental self-medication with antibiotics among parents of different nationalities: a cross-sectional study.
|
| 20 |
patient safety management activities
(1 time)
|
Environmental Health
(1 time)
|
CS (1 time)
|
2021 The Influence of Burnout on Patient Safety Management Activities of Shift Nurses: The Mediating Effect of Compassion Satisfaction.
|
| 21 |
patient-specific meta-analysis
(1 time)
|
Gastrointestinal Neoplasms
(1 time)
|
MMR (1 time)
RS (1 time)
|
2022 Patient-specific meta-analysis of 12-gene colon cancer recurrence score validation studies for recurrence risk assessment after surgery with or without 5FU and oxaliplatin.
|
| 22 |
percutaneous septal myocardial ablation
(1 time)
|
Cardiology
(1 time)
|
LVOT (1 time)
MR (1 time)
SM (1 time)
|
2008 Treatment modalities in hypertrophic obstructive cardiomyopathy: surgical myectomy versus percutaneous septal ablation.
|
| 23 |
performance ofprostate-specific membrane antigen
(1 time)
|
Neoplasms
(1 time)
|
---
|
2021 A Pilot Study of18F-DCFPyL PET/CT or PET/MRI and Ultrasound Fusion Targeted Prostate Biopsy for Intra-Prostatic PET-Positive Lesions.
|
| 24 |
Physical Shared Medical Appointment
(1 time)
|
Neoplasms
(1 time)
|
---
|
2008 Group medical appointments: organization and implementation in the bone marrow transplantation clinic.
|
| 25 |
poly(sodium methacrylate)
(1 time)
|
Chemistry
(1 time)
|
PS (1 time)
|
2009 Surface-initiated free radical polymerization at the liquid-liquid interface: a one-step approach for the synthesis of amphiphilic janus silica particles.
|
| 26 |
poly(stearyl methacrylate)
(1 time)
|
Chemistry
(1 time)
|
CPDB (1 time)
PISA (1 time)
PTFEMA (1 time)
|
2021 Synthesis of Highly Transparent Diblock Copolymer Vesicles via RAFT Dispersion Polymerization of 2,2,2-Trifluoroethyl Methacrylate in n-Alkanes.
|
| 27 |
poly(styrene- co-methacrylic acid)
(1 time)
|
Biomedical Engineering
(1 time)
|
LOD (1 time)
|
2018 Electronic Cortisol Detection Using an Antibody-Embedded Polymer Coupled to a Field-Effect Transistor.
|
| 28 |
polysolketal methacrylate
(1 time)
|
Polymers
(1 time)
|
PS-b-PSMA (2 times)
PS-b-PGMA (1 time)
SEM (1 time)
|
2017 Block Copolymer Membranes from Polystyrene-b-poly(solketal methacrylate) (PS-b-PSMA) and Amphiphilic Polystyrene-b-poly(glyceryl methacrylate) (PS-b-PGMA).
|
| 29 |
positron emission tomography
(1 time)
|
Neoplasms
(1 time)
|
---
|
2023 Treatments and challenges in advanced prostate cancer.
|
| 30 |
post-stroke memory assessment
(1 time)
|
Mental Disorders
(1 time)
|
---
|
2014 Cognitive impairment and memory dysfunction after a stroke diagnosis: a post-stroke memory assessment.
|
| 31 |
post-stroke motor aphasia
(1 time)
|
Neurology
(1 time)
|
BA (1 time)
CER (1 time)
CrI (1 time)
|
2023 Comparison of the efficacy of acupuncture-related Therapies for post-stroke motor aphasia: A Bayesian network meta-analysis.
|
| 32 |
primary motor spinal atrophy
(1 time)
|
Neurology
(1 time)
|
ALS (1 time)
PBP (1 time)
PLS (1 time)
|
1998 [Median nerve electrophysiological assessment in amyotrophic lateral sclerosis].
|
| 33 |
Primary septic meningococcal arthritis
(1 time)
|
Rheumatology
(1 time)
|
---
|
1994 Recurrent sterile arthritis following primary septic meningococcal arthritis.
|
| 34 |
printed square monopole antenna
(1 time)
|
|
h-stroke (1 time)
i-stroke (1 time)
MTS (1 time)
|
2021 Metasurface-Enhanced Antennas for Microwave Brain Imaging.
|
| 35 |
probabilistic surface of molecular activity
(1 time)
|
Informatics
(1 time)
|
AUC (1 time)
MCC (1 time)
PCooA (1 time)
|
2019 A visual approach for analysis and inference of molecular activity spaces.
|
| 36 |
program-PRO-SELF: Mouth Aware
(1 time)
|
Neoplasms
(1 time)
|
---
|
1996 Randomized clinical trial of chlorhexidine versus placebo for prevention of oral mucositis in patients receiving chemotherapy.
|
| 37 |
progressive screening memetic algorithm
(1 time)
|
Biology
(1 time)
|
GWAS (1 time)
SNPs (1 time)
|
2020 Detecting Disease-Associated SNP-SNP Interactions Using Progressive Screening Memetic Algorithm.
|
| 38 |
propensity score matching method
(1 time)
|
|
HR (1 time)
MBC (1 time)
|
2023 Real-world effect of bevacizumab and eribulin on metastatic breast cancer using a propensity score matching analysis.
|
| 39 |
prostate cancer cell lines were treated with immunotoxin A-dmDT390-scfbDb
(1 time)
|
Biocompatible Materials
(1 time)
|
DT (1 time)
|
2012 An anti-PSMA bivalent immunotoxin exhibits specificity and efficacy for prostate cancer imaging and therapy.
|
| 40 |
prostate or metastatic lesions. F-prostate specific membrane antigen
(1 time)
|
Urology
(1 time)
|
CT (1 time)
FDG-PET (1 time)
PSA (1 time)
|
2022 [A Case of Pelvic Lymph Node Recurrence Detected by PSMA PET/CT after Primary Proton Beam Radiotherapy for Prostate Cancer].
|
| 41 |
prostate specific antigen membrane
(1 time)
|
Nuclear Medicine
(1 time)
|
FDG (1 time)
PC (1 time)
PET (1 time)
|
2021 PET/CT Variants and Pitfalls in Prostate Cancer: What You Might See on PET and Should Never Forget.
|
| 42 |
Prostate specific monoclonal antibody
(1 time)
|
Nuclear Medicine
(1 time)
|
18 F-FDG (1 time)
68 Ga (1 time)
BM (1 time)
|
2019 More advantages in detecting bone and soft tissue metastases from prostate cancer using 18F-PSMA PET/CT.
|
| 43 |
Prostate-specific Membrane Antigen Protein Expression
(1 time)
|
Urologic Diseases
(1 time)
|
CI (1 time)
CRPC (1 time)
IHC (1 time)
|
2021 Single-lesion Prostate-specific Membrane Antigen Protein Expression (PSMA) and Response to [177Lu]-PSMA-ligand Therapy in Patients with Castration-resistant Prostate Cancer.
|
| 44 |
prostate-specific membrane antigen radiotracers
(1 time)
|
Diagnostic Imaging
(1 time)
|
HER2 (1 time)
SSTRs (1 time)
|
2023 The Role of Theragnostics in Breast Cancer: A Systematic Review of the Last 12 Years.
|
| 45 |
prostatectomy; additionally, investigate the benefits of rostate-specific membrane antigen
(1 time)
|
Radiology
(1 time)
|
MRI (1 time)
PET (1 time)
|
2020 Comparison of MRI, PSMA PET/CT, and Fusion PSMA PET/MRI for Detection of Clinically Significant Prostate Cancer.
|
| 46 |
proteasome alpha
(1 time)
|
|
---
|
2021 Prognostic and Genomic Analysis of Proteasome 20S Subunit Alpha (PSMA) Family Members in Breast Cancer.
|
| 47 |
proteasome subunit alpha-type
(1 time)
|
Cell Biology
(1 time)
|
HSP70 (1 time)
HUVECs (1 time)
|
2018 c-Src kinase contributes on endothelial cells mechanotransduction in a heat shock protein 70-dependent turnover manner.
|
| 48 |
proximal spinal muscular atrophies
(1 time)
|
Neurology
(1 time)
|
---
|
1982 [Proximal spinal muscular atrophies].
|
| 49 |
PS Membrane Antigen
(1 time)
|
Urology
(1 time)
|
BSCK (1 time)
GUSB (1 time)
IHC (1 time)
|
2012 Molecular diagnostic tools for the detection of nodal micrometastases in prostate cancer patients undergoing radical prostatectomy with extended pelvic lymph node dissection: a prospective study.
|
| 50 |
psammaplin A
(1 time)
|
Chemistry
(1 time)
|
DBCH (1 time)
HDAC (1 time)
|
2003 The discovery of NVP-LAQ824: from concept to clinic.
|
| 51 |
pseudoaneurysm of the superior mesenteric artery
(1 time)
|
Transplantation
(1 time)
|
AVF (1 time)
SMV (1 time)
SPK (1 time)
|
2000 Vascular complications following bladder drained, simultaneous pancreas-kidney transplantation: the University of Miami experience.
|
| 52 |
PSMA-overexpressing PC-3
(1 time)
|
Molecular Biology
(1 time)
|
BCa (1 time)
BN (1 time)
GRPR (1 time)
|
2022 Investigation of Tumor Cells and Receptor-Ligand Simulation Models for the Development of PET Imaging Probes Targeting PSMA and GRPR and a Possible Crosstalk between the Two Receptors.
|
| 53 |
PSMA-PET/CT
(1 time)
|
Urology
(1 time)
|
PC (1 time)
|
2019 [Prostate-specific membrane antigen (PSMA)-based diagnostics and treatment of prostate cancer].
|
| 54 |
PSMAext
(1 time)
|
Neoplasms
(1 time)
|
PCas (1 time)
|
2000 In vitro characterization of radiolabeled monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen.
|
| 55 |
Tc-prostate-specific membrane antigen antibody fragment
(1 time)
|
Transplantation
(1 time)
|
IRI (1 time)
SPECT (1 time)
|
2015 Noninvasive Imaging of Activated Complement in Ischemia-Reperfusion Injury Post-Cardiac Transplant.
|
| 56 |
Trials-68Ga-Prostate-Specific Member Antigen
(1 time)
|
Radiology
(1 time)
|
---
|
2019 Section Editor's Notebook: Prostate Cancer Theranosis in Clinical Practice and in Clinical Trials-68Ga-Prostate-Specific Member Antigen (PSMA)-11 PET/CT and 177Lu-PSMA-617 Therapy.
|
A Search Service for Abbreviation / Long Form